Begin with the actual route on the prescription
Strut Health lists both a subcutaneous injection and a sublingual lozenge. Joi + Blokes also lists injection and troche selections. These are different product presentations, even when the ingredient is called sermorelin in each. “Oral” on a marketing page should not be assumed to mean a standard swallowed tablet or an interchangeable version of an injection.
Ask the clinician and pharmacist to identify the exact route, formulation and instructions for the proposed product. This is the starting point for comparing convenience or cost, not a detail to leave until after payment.
The published price difference is only one difference
Strut's detailed cards show $119 for the injection and $99 for a 30-day lozenge supply. The $20 difference is an observed price comparison between two listings, not a measure of clinical value. The products may differ in administration, absorption, available evidence and suitability for an individual.
Keep separate rows for the injection and lozenge in a cost worksheet. Record quantity, supply period and care inclusions for each. Do not describe one as a cheaper equivalent unless evidence for that specific equivalence has actually been established.
Ask whether the evidence uses the same formulation
A study of an injected growth-hormone-releasing hormone intervention does not automatically support a sublingual compounded product. Even studies within the same hormone pathway may involve different molecules. One controlled trial often discussed in this field used tesamorelin, which should not be relabeled as a trial of oral sermorelin.
Ask the prescriber for evidence relevant to the exact formulation and the outcome you want to address. If that evidence is limited, uncertainty belongs in the discussion. A needle-free route can be a preference without becoming a proven clinical substitute for another route.
Convenience includes storage and reliable use
A lozenge avoids the injection procedure, but that does not establish that it has no handling requirements. Strut's page tells readers to follow pharmacy refrigeration directions for both formats. Ask for the actual storage instructions, beyond-use date and travel advice for the product that will be dispensed.
For an injection, clarify the supplied equipment and whether preparation is needed. For a lozenge, ask about the full ingredient list and how it should be used according to the label. In either case, resolve difficulties with the clinician rather than improvising a schedule or changing routes yourself.
The medical decision and the subscription should stay connected
If a clinician changes the format, confirm that the prior subscription is canceled or altered before the next refill is processed. Ask whether there is a new consultation, a price change or an unused balance. Switching a product medically does not necessarily update every payment instruction automatically.
Both types of compounded products are not FDA-approved. Neither a lower price nor a familiar ingredient name removes the need for an individualized assessment. A useful comparison makes the route-specific evidence, practical requirements and commercial terms visible together, so the treatment choice is not reduced to avoiding a needle or saving twenty dollars.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.